The histamine H₄ receptor in autoimmune disease

Bibliography

• DE ESCH IJP, THURMOND RL, JONGEJAN A, LEURS R: The histamine H4 receptor as a new therapeutic target for inflammation. Trends Pharmacol. Sci. (2005) 26(9):462-469.
   PubMed Web of Science ®Google Scholar
• BARGER G, DALE HH: Chemical structure and sympathomimetic action of amines. J. Physiol. (Lond.) (1910) 41:19-59.
   Google Scholar
• ASH ASF, SCHILD JO: Receptors mediating some action of histamine. Br. J. Pharmacol. (1966) 27(2):427-439.
   PubMed Web of Science ®Google Scholar
• SIMONS FER: H1-antihistamines: more relevant than ever in the treatment of allergic disorders. J. Allergy Clin. Immunol. (2003) 112(Suppl. 4):S42-S52.
   PubMed Web of Science ®Google Scholar
• SOLL AH, WALSH JH: Regulation of gastric acid secretion. Ann. Rev. Physiol. (1979) 41:35-53.
   PubMed Web of Science ®Google Scholar
• ARRANG JM, GARBARG M, SCHWARTZ JC: Autoinhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature (1983) 302(5911):832-837.
   PubMed Web of Science ®Google Scholar
• LEURS R, BAKKER RA, TIMMERMAN H, DE ESCH IJP: The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat. Rev. Drug Discov. (2005) 4(2):107-120.
   PubMed Web of Science ®Google Scholar
• NAKAMURA T, ITADANI H, HIDAKA Y, OHTA M, TANAKA K: Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem. Biophys. Res. Commun. (2000) 279(2):615-620.
   PubMed Web of Science ®Google Scholar
• ODA T, MORIKAWA N, SAITO Y, MASUHO Y, MATSUMOTO S: Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J. Biol. Chem. (2000) 275(47):36781-36786.
   PubMed Web of Science ®Google Scholar
• LIU C, MA X-J, JIANG X et al.: Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Mol. Pharmacol. (2001) 59(3):420-426.
   PubMed Web of Science ®Google Scholar
• ZHU Y, MICHALOVICH D, WU H et al.: Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol. Pharmacol. (2001) 59(3):434-441.
   PubMed Web of Science ®Google Scholar
• NGUYEN T, SHAPIRO DA, GEORGE SR et al.: Discovery of a novel member of the histamine receptor family. Mol. Pharmacol. (2001) 59(3):427-433.
   PubMed Web of Science ®Google Scholar
• MORSE KL, BEHAN J, LAZ TM et al.: Cloning and characterization of a novel human histamine receptor. J. Pharmacol. Exp. Ther. (2001) 296(3):1058-1066.
   PubMed Web of Science ®Google Scholar
• O’DONNELL N, DUNFORD PJ, THURMOND RL: The histamine H4 receptor: drug discovery in the post-genomic era. In: Immunogenomics and human disease. Falus A (Ed.) Wiley, West Sussex, UK (2006):395-406.
   Google Scholar
• LIU C, WILSON SJ, KUEI C, LOVENBERG TW: Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J. Pharmacol. Exp. Ther. (2001) 299(1):121-130.
   PubMed Web of Science ®Google Scholar
• ODA T, MATSUMOTO S-I, MASUHO Y et al.: cDNA cloning and characterization of porcine histamine H4 receptor. Biochim. Biophys. Acta (2002) 1575(1-3):135-138.
   PubMed Web of Science ®Google Scholar
• ODA T, MATSUMOTO S-I, MATSUMOTO M et al.: Molecular cloning of monkey histamine H4 receptor. J. Pharmacol. Sci. (2005) 98(3):319-322.
   PubMed Web of Science ®Google Scholar
• HOFSTRA CL, DESAI PJ, THURMOND RL, FUNG-LEUNG W-P: Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. (2003) 305(3):1212-1221.
   PubMed Web of Science ®Google Scholar
• THURMOND RL, DESAI PJ, DUNFORD PJ et al.: A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J. Pharmacol. Exp. Ther. (2004) 309(1):404-413.
   PubMed Web of Science ®Google Scholar
• RAIBLE DG, SCHULMAN ES, DIMUZIO J, CARDILLO R, POST TJ: Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. J. Immunol. (1992) 148(11):3536-3542.
   PubMed Web of Science ®Google Scholar
• RAIBLE DG, LENAHAN T, FAYVILEVICH Y, KOSINSKI R, SCHULMAN ES: Pharmacologic characterization of a novel histamine receptor on human eosinophils. Am. J. Respir. Crit. Care Med. (1994) 149(6):1506-1511.
   PubMed Web of Science ®Google Scholar
• BUCKLAND KF, WILLIAMS TJ, CONROY DM: Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor. Br. J. Pharmacol. (2003) 140(6):1117-1127.
   PubMed Web of Science ®Google Scholar
• FUNG-LEUNG W-P, THURMOND RL, LING P, KARLSSON L: Histamine H4 receptor antagonists: the new antihistamines? Curr. Opin. Investig. Drugs (2004) 5(11):1174-1183.
   PubMedGoogle Scholar
• GUTZMER R, DIESTEL C, MOMMERT S et al.: Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J. Immunol. (2005) 174(9):5224-5232.
   PubMed Web of Science ®Google Scholar
• IKAWA Y, SUZUKI M, SHIONO S et al.: Histamine H4 receptor expression in human synovial cells obtained from patients suffering from rheumatoid arthritis. Biol. Pharm. Bull. (2005) 28(10):2016-2018.
   PubMed Web of Science ®Google Scholar
• LING P, NGO K, NGUYEN S et al.: Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br. J. Pharmacol. (2004) 142(1):161-171.
   PubMed Web of Science ®Google Scholar
• GANTNER F, SAKAI K, TUSCHE MW et al.: Histamine H4 and H2 receptors control histamine-induced interleukin-16 release from human CD8+ T cells. J. Pharmacol. Exp. Ther. (2002) 303(1):300-307.
   PubMed Web of Science ®Google Scholar
• COGE F, GUENIN SP, RIQUE H, BOUTIN JA, GALIZZI JP: Structure and expression of the human histamine H4-receptor gene. Biochem. Biophys. Res. Commun. (2001) 284(2):301-309.
   PubMed Web of Science ®Google Scholar
• CIANCHI F, CORTESINI C, SCHIAVONE N et al.: The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Clin. Cancer Res. (2005) 11(19 Part 1):6807-6815.
   PubMed Web of Science ®Google Scholar
• O’REILLY M, ALPERT R, JENKINSON S et al.: Identification of a histamine H4 receptor on human eosinophils – role in eosinophil chemotaxis. J. Recept. Signal Trans. Res. (2002) 22(1-4):431-448.
   PubMed Web of Science ®Google Scholar
• BAKKER RA, SCHOONUS SBJ, SMIT MJ, TIMMERMAN H, LEURS R: Histamine H1-receptor activation of nuclear factor-κB: roles for Gbg- and Gaq/11-subunits in constitutive and agonist-mediated signaling. Mol. Pharmacol. (2001) 60(5):1133-1142.
   PubMed Web of Science ®Google Scholar
• LEURS R, SMIT MJ, MENGE WM, TIMMERMAN H: Pharmacological characterization of the human histamine H4 receptor stably expressed in Chinese hamster ovary cells. Br. J. Pharmacol. (1994) 112(3):847-854.
   PubMed Web of Science ®Google Scholar
• JABLONOWSKI JA, CARRUTHERS NI, THURMOND RL: The histamine H4 receptor and potential therapeutic uses for H4 ligands. Mini-Rev. Med. Chem. (2004) 4(9):993-1000.
   PubMed Web of Science ®Google Scholar
• STARK H: Recent advances in histamine H3/H4 receptor ligands. Expert Opin. Ther. Pat. (2003) 13(6):851-865.
   Web of Science ®Google Scholar
• LIM HD, VAN RIJN RM, LING P et al.: Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist. J. Pharmacol. Exp. Ther. (2005) 314(3):1310-1321.
   PubMed Web of Science ®Google Scholar
• GBAHOU F, VINCENT L, HUMBERT-CLAUDE M et al.: Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives. Br. J. Pharmacol. (2006) 147(7):744-754.
   PubMed Web of Science ®Google Scholar
• JABLONOWSKI JA, GRICE CA, CHAI W et al.: The first potent and selective non-imidazole human histamine H4 receptor antagonists. J. Med. Chem. (2003) 46(19):3957-3960.
   PubMed Web of Science ®Google Scholar
• VENABLE JD, CAI H, CHAI W et al.: Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine H4 antagonists. J. Med. Chem. (2005) 48(26):8289-8298.
   PubMed Web of Science ®Google Scholar
• TERZIOGLU N, VAN RIJN RM, BAKKER RA, DE ESCH IJP, LEURS R: Synthesis and structure–activity relationships of indole and benzimidazole piperazines as histamine H4 receptor antagonists. Bioorg. Med. Chem. Lett. (2004) 14(21):5251-5256.
   PubMed Web of Science ®Google Scholar
• HASHIMOTO T, HARUSAWA S, ARAKI L et al.: A selective human H4-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5- [1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine. J. Med. Chem. (2003) 46(14):3162-3165.
   PubMed Web of Science ®Google Scholar
• HARUSAWA S, ARAKI L, IMAZU T et al.: Synthesis of (+/-)-trans- or cis-(5-aminomethyltetrahydrofuranyl)- imidazole by Mitsunobu cyclization: synthetic studies toward novel histamine H3 or H4-ligands. Chem. Pharm. Bull. (2003) 51(3):325-329.
   PubMed Web of Science ®Google Scholar
• IDZKO M, LA SALA A, FERRARI D et al.: Expression and function of histamine receptors in human monocyte-derived dendritic cells. J. Allergy Clin. Immunol. (2002) 109(5):839-846.
   PubMed Web of Science ®Google Scholar
• DUNFORD PJ, O’DONNELL N, RILEY JP et al.: The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J. Immunol. (2006) 176(11):7062-7070.
   PubMed Web of Science ®Google Scholar
• TAKESHITA K, SAKAI K, BACON KB, GANTNER F: Critical role of histamine H4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo. J. Pharmacol. Exp. Ther. (2003) 307(3):1072-1078.
   PubMed Web of Science ®Google Scholar
• VARGA C, HORVATH K, BERKO A et al.: Inhibitory effects of histamine H4 receptor antagonists on experimental colitis in the rat. Eur. J. Pharmacol. (2005) 522(1-3):130-138.
   PubMed Web of Science ®Google Scholar
• FOGEL WA, WAGNER W, SASIAK K, STASIAK A: The role of histamine in experimental ulcerative colitis in rats. Inflamm. Res. (2005) 54:S68-S69 (Supplement).
   PubMed Web of Science ®Google Scholar
• STEINMAN L: Immune therapy for autoimmune diseases. Science (2004) 305(5681):212-216.
   PubMed Web of Science ®Google Scholar
• GOODNOW CC, SPRENT J, FAZEKAS DE ST GROTH B, VINUESA CG: Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature (2005) 435(7042):590-597.
   PubMed Web of Science ®Google Scholar
• TURLEY SJ: Dendritic cells: inciting and inhibiting autoimmunity. Curr. Opin. Immunol. (2002) 14(6):765-770.
   PubMed Web of Science ®Google Scholar
• SUN S, THURMOND RL, KARLSSON L: Antigen presenting cells as drug targets. In: Antigen presenting cells: from mechanisms to drug development. Kropshofer H, Vogt AB (Eds), Wiley-VCH, Weinheim, Germany (2005):541-584.
   Google Scholar
• TRAN CN, LUNDY SK, FOX DA: Synovial biology and T cells in rheumatoid arthritis. Pathophysiology (2005) 12(3):183-189.
   PubMedGoogle Scholar
• NEWTON JL, HARNEY SMJ, WORDSWORTH BP, BROWN MA: A review of the MHC genetics of rheumatoid arthritis. Genes Immunol. (2004) 5(3):151-157.
   PubMed Web of Science ®Google Scholar
• MORELAND L, BATE G, KIRKPATRICK P: Abatacept. Nat. Rev. Drug Discov. (2006) 5(3):185-186.
   PubMed Web of Science ®Google Scholar
• McINTYRE JA, GARCIA-CAPDEVILA L, BAYES M: Abatacept: treatment of rheumatoid arthritis agent for systemic lupus erythematosus. Drugs Future (2006) 31(1):7-16.
   Web of Science ®Google Scholar
• PEDOTTI R, DE VOSS JJ, STEINMAN L, GALLI SJ: Involvement of both ‘allergic’ and ‘autoimmune’ mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. (2003) 24(9):479-484.
   PubMed Web of Science ®Google Scholar
• PEDOTTI R, STEINMAN L: Histamine in immune regulation: possible roles in autoimmune demyelinating disease of the central nervous system. Curr. Med. Chem. (2005) 4(6):637-643.
   Google Scholar
• ROBBIE-RYAN M, BROWN MA: The role of mast cells in allergy and autoimmunity. Curr. Opin. Immunol. (2002) 14(6):728-733.
   Web of Science ®Google Scholar
• ROTTEM M, MEKORI YA: Mast cells and autoimmunity. Autoimmun. Rev. (2005) 4(1):21-27.
   Web of Science ®Google Scholar
• JUTEL M, WATANABE T, KLUNKER S et al.: Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature (2001) 413(6854):420-425.
   PubMed Web of Science ®Google Scholar
• TUOMISTO L, KILPELAINEN H, RIEKKINEN P: Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. Agents Actions (1983) 13(2-3):255-257.
   PubMedGoogle Scholar
• PETERSEN LJ, HANSEN U, KRISTENSEN JK et al.: Studies on mast cells and histamine release in psoriasis: the effect of ranitidine. Acta Derm. Venereol. (1998) 78(3):190-193.
   Google Scholar
• FREWIN DB, CLELAND LG, JONSSON JR, ROBERTSON PW: Histamine levels in human synovial fluid. J. Rheumatol. (1986) 13(1):13-14.
   Google Scholar
• CRISP AJ: Studies of histamine in the rheumatoid joint. Rheumatol. Int. (1984) 4(3):125-128.
   Web of Science ®Google Scholar
• WINTERKAMP S, WEIDENHILLER M, OTTE P et al.: Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease. Am. J. Gastroenterol. (2002) 97(12):3071-3077.
   Web of Science ®Google Scholar
• BISCHOFF SC, GRABOWSKY J, MANNS MP: Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig. Dis. Sci. (1997) 42(2):394-403.
   Web of Science ®Google Scholar
• RAITHEL M, MATEK M, BAENKLER HW, JORDE W, HAHN EG: Mucosal histamine content and histamine secretion in Crohn’s disease, ulcerative colitis and allergic enteropathy. Int. Arch. Allergy Immunol. (1995) 108(2):127-133.
   PubMed Web of Science ®Google Scholar
• GARCIA-MARTIN E, MENDOZA JL, MARTINEZ C et al.: Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene. World J. Gastroenterol. (2006) 12(4):615-620.
   Web of Science ®Google Scholar
• BENE L, SAPI Z, BAJTAI A et al.: Partial protection against dextran sodium sulphate induced colitis in histamine-deficient, histidine decarboxylase knockout mice. J. Pediatr. Gastroenterol. Nutr. (2004) 39(2):171-176.
   PubMed Web of Science ®Google Scholar
• MUSIO S, GALLO B, SCABENI S et al.: A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice. J. Immunol. (2005) 176(1):17-26.
   Web of Science ®Google Scholar
• GOREN N, PEREZ LEIROS C, STERIN-BORDA L, BORDA E: Effect of histamine in autoimmune myocarditis mice. Int. J. Immunopharmacol. (1994) 16(9):737-745.
   PubMed Web of Science ®Google Scholar
• GOREN N, STERIN-BORDA L, PEREZ LEIROS C, BORDA ES: Increases in cyclic AMP levels couple to H1 receptors in atria from autoimmune myocarditis mice. Cell Signal. (1995) 7(8):759-764.
   PubMed Web of Science ®Google Scholar
• GOREN N, STERIN-BORDA L, BARTRONS R, GOMEZ R, BORDA E: Detection of mRNA encoding H1 receptor and iNOS by RT-PCR in autoimmune myocarditis with special reference to changes in heart contractility. Int. J. Cardiol. (2000) 76(2-3):165-172.
   PubMed Web of Science ®Google Scholar
• IBRAHIM MZM, REDER AT, LAWAND R, TAKASH W, SALLOUH-KHATIB S: The mast cells of the multiple sclerosis brain. J. Neuroimmunol. (1996) 70(2):131-138.
   PubMed Web of Science ®Google Scholar
• TOMS R, WEINER HL, JOHNSON D: Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J. Neuroimmunol. (1990) 30(2-3):169-177.
   PubMed Web of Science ®Google Scholar
• ZAPPULLA JP, AROCK M, MARS LT, LIBLAU RS: Mast cells: new targets for multiple sclerosis therapy? J. Neuroimmunol. (2002) 131(1-2):5-20.
   PubMed Web of Science ®Google Scholar
• KRUGER PG, BO L, MYHR KM et al.: Mast cells and multiple sclerosis: a light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures. Acta Neurol. Scand. (1990) 81(1):31-36.
   PubMed Web of Science ®Google Scholar
• SECOR VH, SECOR WE, GUTEKUNST C-A, BROWN MA: Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. (2000) 191(5):813-821.
   PubMed Web of Science ®Google Scholar
• BROWN MA, TANZOLA MB, ROBBIE-RYAN M: Mechanisms underlying mast cell influence on EAE disease course. Mol. Immunol. (2002) 38(16-18):1373-1378.
   PubMed Web of Science ®Google Scholar
• WOOLLEY DE: The mast cell in inflammatory arthritis. N. Engl. J. Med. (2003) 348(17):1709-1711.
   PubMed Web of Science ®Google Scholar
• CRISP AJ: Mast cells in rheumatoid arthritis. J. R. Soc. Med. (1984) 77(6):450-451.
   PubMed Web of Science ®Google Scholar
• GODFREY HP, ILARDI C, ENGBER W, GRAZIANO FM: Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum. (1984) 27(8):852-856.
   PubMed Web of Science ®Google Scholar
• GOTIS-GRAHAM I, SMITH MD, PARKER A, McNEIL HP: Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Ann. Rheum. Dis. (1998) 57(11):664-671.
   PubMed Web of Science ®Google Scholar
• TETLOW LC, WOOLLEY DE: Eosinophils are an insignificant cellular component of rheumatoid synovium in patients with late stage disease: comparative distributions with mast cells and macrophages. Ann. Rheum. Dis. (1996) 55(8):548-551.
   PubMed Web of Science ®Google Scholar
• TETLOW LC, WOOLLEY DE: Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann. Rheum. Dis. (1995) 54(7):549-555.
   PubMed Web of Science ®Google Scholar
• GOTIS-GRAHAM I, McNEIL PH: Mast cell responses in rheumatoid synovium. Association of the MCTC subset with matrix turnover and clinical progression. Arthritis Rheum. (1997) 40(3):479-489.
   PubMedGoogle Scholar
• TETLOW LC, WOOLLEY DE: Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalization studies. Ann. Rheum. Dis. (1995) 54(11):896-903.
   PubMed Web of Science ®Google Scholar
• BRIDGES AJ, MALONE DG, JICINSKY J et al.: Human synovial mast cell involvement in rheumatoid arthritis and osteoarthritis. Relationship to disease type, clinical activity, and antirheumatic therapy. Arthritis Rheum. (1991) 34(9):1116-1124.
   PubMed Web of Science ®Google Scholar
• DVORAK AM, McLEOD RS, ONDERDONK A et al.: Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int. Arch. Allergy Immunol. (1992) 99(1):74-83.
   PubMed Web of Science ®Google Scholar
• KING T, BIDDLE W, BHATIA P, MOORE J, MINER PB Jr: Colonic mucosal mast cell distribution at line of demarcation of active ulcerative colitis. Dig. Dis. Sci. (1992) 37(4):490-495.
   PubMed Web of Science ®Google Scholar
• BALAZS M, ILLYES G, VADASZ G: Mast cells in ulcerative colitis. Quantitative and ultrastructural studies. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. (1989) 57(6):353-360.
   PubMedGoogle Scholar
• HE S-H: Key role of mast cells and their major secretory products in inflammatory bowel disease. World J. Gastroenterol. (2004) 10(3):309-318.
   PubMed Web of Science ®Google Scholar
• ROTTEM M: Chronic urticaria and autoimmune thyroid disease: is there a link? Autoimmun. Revs (2003) 2(2):69-72.
   PubMed Web of Science ®Google Scholar
• ROTTEM M, GERSHWIN ME, SHOENFELD Y: Allergic disease and autoimmune effectors pathways. Dev. Immunol. (2002) 9(3):161-167.
   PubMedGoogle Scholar
• SKOPOULI FN, LI L, BOUMBA D et al.: Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjogren’s syndrome. Clin. Exp. Rheumatol. (1998) 16(1):63-65.
   PubMed Web of Science ®Google Scholar
• TUVERI MA, PASSIU G, MATHIEU A, ALOE L: Nerve growth factor and mast cell distribution in the skin of patients with systemic sclerosis. Clin. Exp. Rheumatol. (1993) 11(3):319-322.
   PubMed Web of Science ®Google Scholar
• KUBO Y, NAKANO K: Regulation of histamine synthesis in mouse CD4+ and CD8+ T lymphocytes. Inflamm. Res. (1999) 48(3):149-153.
   PubMed Web of Science ®Google Scholar
• TAKAMATSU S, NAKASHIMA I, NAKANO K: Modulation of endotoxin-induced histamine synthesis by cytokines in mouse bone marrow-derived macrophages. J. Immunol. (1996) 156(2):778-785.
   PubMed Web of Science ®Google Scholar
• OKAMOTO H, NAKANO K: Regulation of interleukin-1 synthesis by histamine produced by mouse peritoneal macrophages per se. Immunology (1990) 69(1):162-165.
   PubMed Web of Science ®Google Scholar
• SZEBERENYI JB, PALLINGER E, ZSINKO M et al.: Inhibition of effects of endogenously synthesized histamine disturbs in vitro human dendritic cell differentiation. Immunol. Lett. (2001) 76(3):175-182.
   PubMed Web of Science ®Google Scholar
• AOI R, NAKASHIMA I, KITAMURA Y, ASAI H, NAKANO K: Histamine synthesis by mouse T lymphocytes through induced histidine decarboxylase. Immunology (1989) 66(2):219-223.
   PubMed Web of Science ®Google Scholar
• SONOBE Y, NAKANE H, WATANABE T, NAKANO K: Regulation of Con A-dependent cytokine production from CD4+ and CD8+ T lymphocytes by autosecretion of histamine. Inflamm. Res. (2004) 53(3):87-92.
   PubMed Web of Science ®Google Scholar
• AKDIS CA, SIMONS FER: Histamine receptors are hot in immunopharmacology. Eur. J. Pharmacol. (2006) 533(1-3):69-76.
   PubMed Web of Science ®Google Scholar